Drug Shortage Report for ZELDOX
Report ID | 116011 |
Drug Identification Number | 02298600 |
Brand name | ZELDOX |
Common or Proper name | Zeldox |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ZIPRASIDONE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 60's |
ATC code | N05AE |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-05-27 |
Estimated end date | |
Actual end date | 2020-07-13 |
Shortage status | Resolved |
Updated date | 2020-07-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-07-13 | French | Compare |
v8 | 2020-07-13 | English | Compare |
v7 | 2020-07-06 | French | Compare |
v6 | 2020-07-06 | French | Compare |
v5 | 2020-07-06 | English | Compare |
v4 | 2020-06-23 | French | Compare |
v3 | 2020-06-23 | English | Compare |
v2 | 2020-05-28 | French | Compare |
v1 | 2020-05-28 | English | Compare |
Showing 1 to 9 of 9